Stuart Roberts

Stuart Roberts is an Adjunct Clinical Professor in the Department of Gastroenterology at Monash University, Faculty of Medicine, Nursing and Health Sciences. He is actively engaged in clinical research focusing on liver diseases, with a strong emphasis on chronic viral hepatitis, primary liver cancer, non-alcoholic fatty liver disease (NAFLD/MASLD), and non-invasive liver diagnostics such as Fibroscan.

• University: Monash University
• School: Faculty of Medicine, Nursing and Health Sciences
• Department: Department of Gastroenterology
• Academic Rank: Adjunct Clinical Professor

His research interests center on advancing therapeutic strategies for chronic liver diseases through clinical trials and translational studies. Key areas include evaluating novel antiviral and immunomodulatory agents for hepatitis B and C, assessing new treatments for hepatocellular carcinoma, and investigating metabolic and dietary influences on liver health in aging populations. He also studies the role of liver stiffness measurement in disease screening and prognosis.

The recent publications and active research projects (2024–2025) reflect a strong trend toward understanding the intersection of liver disease with aging, cardiovascular health, and neurocognitive outcomes. His work increasingly focuses on metabolic dysfunction-associated steatotic liver disease (MASLD), its systemic complications, and lifestyle or pharmacological interventions. Multiple phase 1 to phase 3 clinical trials are underway, particularly in NASH/MASH, hepatitis B immunotherapy, and cholangiocarcinoma.

Scientific Awards:

• No awards mentioned in the provided text.

Advising and Grants:
Dr. Roberts serves as Primary Chief Investigator on 42 research projects, including major industry-sponsored clinical trials in hepatology. His leadership in multicenter studies highlights his role in shaping evidence-based liver disease management. While no formal student advising is mentioned, his collaborations involve trainees and junior researchers. Funding appears to come from pharmaceutical sponsors and institutional sources, supporting trials in antiviral, metabolic, and oncologic liver therapies.

Labs and Research Teams:
Dr. Roberts leads a clinical research team focused on hepatology within Monash Health. His work is highly collaborative, involving dietitians, oncologists, geriatricians, and neurologists. The research network includes national and international partners, with a strong presence in Australian multicenter liver disease studies.